Glaxo and AstraZeneca Clash on Asthma Drug Claims (Reuters)


Reuters - GlaxoSmithKline Plc said on Thursday its
asthma drug Advair/Seretide beat AstraZeneca Plc's Symbicort in
a 1-year clinical study, reviving rival claims about the two
products.

Read more...